Skip to main content

Table 4 The comparison of variables in the treatment group (PRP + splint) at the beginning and end of study

From: Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial

Variables

Group

Number

Mean

SD

P value

VAS

Before

21

6.82

1.24

< 0.001

After

21

4.02

1.92

MedSNAP PL

Before

21

4.25

0.52

0.005

After

21

4.12

0.63

MedCMAP OL

Before

21

4.13

0.53

0.472

After

21

4.15

0.52

SSS

Before

21

2.43

0.73

< 0.001

After

21

1.72

0.52

FSS

Before

21

2.36

0.83

0.003

After

21

1.83

0.73